Abiomed
ABMD
#1112
Rank
โ‚ฌ16.41 B
Marketcap
363,94ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Revenue for Abiomed (ABMD)

Revenue in 2022 (TTM): โ‚ฌ1.00 Billion

According to Abiomed's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.02 Billion. In 2021 the company made a revenue of โ‚ฌ0.88 Billion an increase over the revenue in the year 2020 that were of โ‚ฌ0.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abiomed from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ1.00 B13.82%
2021 โ‚ฌ0.88 B34.02%
2020 โ‚ฌ0.66 B-11.99%
2019 โ‚ฌ0.75 B16.61%
2018 โ‚ฌ0.64 B42.05%
2017 โ‚ฌ0.45 B15.03%
2016 โ‚ฌ0.39 B42.16%
2015 โ‚ฌ0.27 B58.17%
2014 โ‚ฌ0.17 B36.86%
2013 โ‚ฌ0.12 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ2.89 B 181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.54 B 1,317.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.42 B-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA